Soleno Therapeutics Inc. buy The Goldman Sachs Group, Inc.
Start price
07.10.25
/
50%
€54.00
Target price
07.10.26
€106.85
Performance (%)
-38.78%
Price
26.02.26
€34.08
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Soleno Therapeutics Inc. is performing very badly with a performance of -38.78%. This prediction currently runs until 07.10.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Soleno Therapeutics Inc. | 2.404% | 2.404% |
| iShares Core DAX® | -0.383% | 1.093% |
| iShares Nasdaq 100 | -0.411% | -1.973% |
| iShares Nikkei 225® | 1.838% | 10.261% |
| iShares S&P 500 | -0.712% | 0.445% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (NASDAQ:SLNO) was given a new $125.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a "buy" rating on the stock.
Ratings data for SLNO provided by MarketBeat